Thermo Fisher Scientific Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Apr 2022 | $33.06B | $40.96B | $2.75B |
| Jul 2022 | $30.06B | $42.29B | $1.89B |
| Oct 2022 | $28.94B | $43.55B | $2.92B |
| Dec 2022 | $34.28B | $43.98B | $8.52B |
| Apr 2023 | $35.05B | $42.26B | $3.48B |
| Jul 2023 | $33.81B | $43.75B | $3.13B |
| Sep 2023 | $35.08B | $45.33B | $6.15B |
| Dec 2023 | $34.73B | $46.74B | $8.08B |
| Mar 2024 | $35.39B | $45.52B | $5.50B |
| Jun 2024 | $35.20B | $47.43B | $7.07B |
| Sep 2024 | $35.11B | $48.99B | $4.65B |
| Dec 2024 | $31.07B | $49.58B | $4.01B |
| Mar 2025 | $33.99B | $49.39B | $4.13B |
| Jun 2025 | $35.03B | $50.51B | $4.58B |
| Sep 2025 | $35.48B | $51.02B | $1.98B |
| Dec 2025 | $39.17B | $53.41B | $9.85B |
| Mar 2026 | $42.95B | $51.93B | $3.25B |
| Jun 2026 | $42.28B | $52.68B | $4.06B |